Ha habido 50 transacciones internas recientes registradas para Virpax Pharmaceuticals, Inc. (VRPX), incluyendo 38 compras y 3 ventas. El total de compras internas fue valorado en $1.98M y el total de ventas internas en $333.22K.
Internos destacados con actividad reciente incluyen Panis Jaydriane, Randhawa Esha, Chaudhry Usama. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — VRPX
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-12-17 |
Panis Jaydriane |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-11-19 |
Randhawa Esha |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-11-18 |
Chaudhry Usama |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-07-05 |
Herman Gary L |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-07-05 |
Herman Gary L |
Director |
Concesión de RSU |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Dhaliwal Jatinder |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-07-05 |
Dhaliwal Jatinder |
Director |
Concesión de RSU |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Field Katharyn |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-07-05 |
Field Katharyn |
Director |
Concesión de RSU |
2,500 |
$0.58 |
$1.45K |
2,500 |
| 2024-07-05 |
Su Judy |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-01-29 |
Bruce Gerald W |
Chief Executive Officer |
Concesión de RSU |
125,000 |
$0.32 |
$39.73K |
125,000 |
| 2024-01-29 |
Shah Vinay |
Chief Financial Officer |
Concesión de RSU |
112,000 |
$0.32 |
$35.59K |
112,000 |
| 2024-01-29 |
Singh Vanila |
Director |
Concesión de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Jambulingam Thani |
Director |
Concesión de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Floyd Eric |
Director |
Concesión de RSU |
45,000 |
$0.32 |
$14.3K |
45,000 |
| 2024-01-29 |
Sendrow Jerrold |
Director |
Concesión de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Dubin Michael F |
Director |
Concesión de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Ruskin Barbara |
Director |
Concesión de RSU |
25,000 |
$0.32 |
$7.95K |
25,000 |
| 2024-01-29 |
Mathias Sheila |
Chief Scientific Officer |
Concesión de RSU |
112,000 |
$0.32 |
$35.59K |
112,000 |
| 2024-01-25 |
Mathias Sheila |
Chief Scientific Officer |
Disposición |
112,000 |
$0.79 |
$88.48K |
- |
| 2023-06-20 |
Shah Vinay |
Chief Financial Officer |
Concesión de RSU |
100,000 |
$0.99 |
$99K |
100,000 |
| 2023-06-20 |
Shah Vinay |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-06-20 |
Shah Vinay |
Chief Financial Officer |
Concesión de RSU |
100,000 |
$0.99 |
$99K |
100,000 |
| 2023-04-24 |
Bruce Gerald W |
Director |
Concesión de RSU |
100,000 |
$0.73 |
$73K |
100,000 |
| 2023-03-24 |
Ruskin Barbara |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-03-24 |
Ruskin Barbara |
Director |
Concesión de RSU |
25,000 |
$0.84 |
$20.91K |
25,000 |
| 2023-01-31 |
Mathias Sheila |
Chief Scientific Officer |
Disposición |
60,676 |
$2.13 |
$129.24K |
- |
| 2023-01-25 |
Chipman Christopher Michael |
Chief Financial Officer |
Concesión de RSU |
112,000 |
- |
- |
112,000 |
| 2023-01-25 |
Gudin Jeffrey |
Chief Medical Officer |
Concesión de RSU |
50,000 |
- |
- |
50,000 |
| 2023-01-25 |
Mack Anthony P. |
Chief Executive Officer |
Concesión de RSU |
125,000 |
- |
- |
125,000 |
| 2023-01-25 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
Concesión de RSU |
125,000 |
$0.87 |
$108.38K |
125,000 |
| 2023-01-01 |
Singh Vanila |
Director |
Concesión de RSU |
15,000 |
- |
- |
15,000 |
| 2023-01-01 |
Jambulingam Thani |
Director |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2023-01-01 |
Floyd Eric |
Director |
Concesión de RSU |
45,000 |
- |
- |
45,000 |
| 2023-01-01 |
Sendrow Jerrold |
Director |
Concesión de RSU |
35,000 |
- |
- |
35,000 |
| 2023-01-01 |
Dubin Michael F |
Director |
Concesión de RSU |
20,000 |
- |
- |
20,000 |
| 2022-05-24 |
Sendrow Jerrold |
Director |
Compra Informativa |
4,500 |
$1.29 |
$5.81K |
9,006 |
| 2022-05-18 |
Floyd Eric |
Director |
Compra Informativa |
4,479 |
$1.36 |
$6.11K |
8,018 |
| 2022-05-18 |
Mack Anthony P. |
Chief Executive Officer |
Compra Informativa |
75,750 |
$1.34 |
$101.51K |
252,562 |
| 2022-04-25 |
Bruce Gerald W |
Director |
Concesión de RSU |
60,000 |
- |
- |
60,000 |
| 2022-04-07 |
Mathias Sheila |
Chief Scientific Officer |
Disposición |
25,000 |
$4.62 |
$115.5K |
- |
| 2022-01-31 |
Chipman Christopher Michael |
Chief Financial Officer |
Concesión de RSU |
100,000 |
$2.13 |
$213K |
100,000 |
| 2022-01-31 |
Gudin Jeffrey |
Chief Medical Officer |
Concesión de RSU |
100,000 |
$2.13 |
$213K |
100,000 |
| 2022-01-31 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
Concesión de RSU |
150,000 |
$2.34 |
$351K |
150,000 |
| 2022-01-31 |
Chipman Christopher Michael |
Chief Financial Officer |
Concesión de RSU |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-31 |
Gudin Jeffrey |
Chief Medical Officer |
Concesión de RSU |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-31 |
Mack Anthony P. |
10 Percent Owner, Officer: Chief Executive Officer |
Concesión de RSU |
60,676 |
$2.13 |
$129.24K |
60,676 |
| 2022-01-01 |
Jacob Gary S |
Director |
Concesión de RSU |
12,091 |
$3.43 |
$41.47K |
12,091 |
| 2022-01-01 |
Singh Vanila |
Director |
Concesión de RSU |
12,091 |
$3.43 |
$41.47K |
12,091 |
| 2022-01-01 |
Jambulingam Thani |
Director |
Concesión de RSU |
14,113 |
$3.43 |
$48.41K |
14,113 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento